Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Cost of Revenue: 2010-2025

Historic Cost of Revenue for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to $1.0 million.

  • ProPhase Labs' Cost of Revenue fell 16.24% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 30.64%. This contributed to the annual value of $6.9 million for FY2024, which is 64.38% down from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Cost of Revenue is $1.0 million, which was up 96.10% from $513,000 recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Cost of Revenue peaked at $20.5 million during Q4 2021, and registered a low of -$2.2 million during Q4 2023.
  • Moreover, its 3-year median value for Cost of Revenue was $1.6 million (2024), whereas its average is $2.6 million.
  • As far as peak fluctuations go, ProPhase Labs' Cost of Revenue spiked by 523.72% in 2021, and later tumbled by 120.51% in 2023.
  • Over the past 5 years, ProPhase Labs' Cost of Revenue (Quarterly) stood at $20.5 million in 2021, then plummeted by 48.68% to $10.5 million in 2022, then plummeted by 120.51% to -$2.2 million in 2023, then surged by 176.04% to $1.6 million in 2024, then dropped by 16.24% to $1.0 million in 2025.
  • Its Cost of Revenue stands at $1.0 million for Q3 2025, versus $513,000 for Q2 2025 and $905,000 for Q1 2025.